Project CBD
MARCH 15, 2023
I was fortunate to cross paths with Raphael Mechoulam, “the father of cannabis research,” at several science conferences over the years. The most memorable occasion was the 22nd annual meeting of the International Cannabinoid Research Society (ICRS) in Freiburg, Germany, in July 2012.
Cannabis Law Report
FEBRUARY 24, 2022
The National Institute on Drug Abuse (NIDA) is renewing its push to promote federally funded research into marijuana as more states enact reform—specifically expressing interest in studies on differing cannabis regulatory models that are in place across the country. Read full report.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
FEBRUARY 1, 2023
Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?
Cannabis Law Report
DECEMBER 14, 2021
The Brand’s Premium Topicals Are Infused with Organic, Medical-Grade Hemp, and Are Hands Down the Most Effective on the Market. The brand has developed a trio of hemp-based topicals — cream, gel, and spray — that leans on a powerful blend of organic ingredients. FORT LAUDERDALE, Fla. , Dec. Those benefits are numerous.
The Cannigma
JULY 1, 2022
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.
Cannabis Law Report
AUGUST 11, 2021
Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. They are a great strategic fit.
Cannabis Law Report
FEBRUARY 28, 2022
In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.
Expert insights. Personalized for you.
157 
Let's personalize your content